55 related articles for article (PubMed ID: 25779999)
1. Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results.
Barron S; Austin RM; Li Z; Zhao C
Am J Clin Pathol; 2015 Apr; 143(4):485-91. PubMed ID: 25779999
[TBL] [Abstract][Full Text] [Related]
2. HPV Cotesting of Unsatisfactory Papanicolaou Tests: Implications for Follow-up Intervals.
Chen F; Hsu Lin L; Hindi I; Sun W; Shafizadeh N; Szeto O; Brandler TC; Simsir A
Am J Clin Pathol; 2023 Aug; 160(2):137-143. PubMed ID: 37052613
[TBL] [Abstract][Full Text] [Related]
3. Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results.
Connelly CF; Collins N; Cimic A; Baskota SU
Am J Clin Pathol; 2023 Nov; 160(5):444-449. PubMed ID: 37418598
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions.
Luo Q; Zeng X; Luo H; Pan L; Huang Y; Zhang H; Han N
BMC Infect Dis; 2023 Oct; 23(1):667. PubMed ID: 37805467
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy and Safety of AdV-tk Gene Therapy for Patients with Cervical Squamous Intraepithelial Lesion: A Prospective Study.
Wang N; Li X; Liu X; Bian M; Hou Y; Zhou Y; Li Y; Xu F; Tang H; Li N; Liu Q
Hum Gene Ther; 2023 Oct; 34(19-20):1033-1040. PubMed ID: 37542389
[TBL] [Abstract][Full Text] [Related]
6. E7 as a Promising Biomarker for Monitoring the Progression of Cervical Lesions in Patients with HPV 16/18 Infections.
Wang H; Shi Y; Sun Y; Zhang A; Wang Y
Altern Ther Health Med; 2023 Nov; 29(8):310-314. PubMed ID: 37632953
[TBL] [Abstract][Full Text] [Related]
7. Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.
Rustagi AS; Kamineni A; Weiss NS
Am J Epidemiol; 2013 Oct; 178(7):1020-2. PubMed ID: 23966563
[TBL] [Abstract][Full Text] [Related]
8. Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study.
Jara Fernández L; Ferrer JÁ; Pérez Calle JL; López Serrano P
Rev Esp Enferm Dig; 2024 May; 116(5):292-293. PubMed ID: 37732357
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of combination of ALA-PDT and interferon for cervical low-grade squamous intraepithelial lesion (LSIL).
Li S; Zhao M; Luo M; Wu J; Duan Z; Huang X; Lu S; Zu Q; Xiao Q; Ying J
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103967. PubMed ID: 38224725
[TBL] [Abstract][Full Text] [Related]
10. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
12. Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.
Stoler MH; Austin RM; Zhao C
J Clin Microbiol; 2015 Sep; 53(9):2798-804. PubMed ID: 25948606
[TBL] [Abstract][Full Text] [Related]
13. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
Johansson H; Bjelkenkrantz K; Darlin L; Dilllner J; Forslund O
PLoS One; 2015; 10(4):e0124460. PubMed ID: 25893988
[TBL] [Abstract][Full Text] [Related]
14. Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia.
Park IU; Wojtal N; Silverberg MJ; Bauer HM; Hurley LB; Manos MM
PLoS One; 2015; 10(3):e0118938. PubMed ID: 25793987
[TBL] [Abstract][Full Text] [Related]
15. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Arbyn M; Snijders PJ; Meijer CJ; Berkhof J; Cuschieri K; Kocjan BJ; Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):817-26. PubMed ID: 25936581
[TBL] [Abstract][Full Text] [Related]
16. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment.
Stanczuk GA; Currie H; Baxter G; Foster A; Gibson L; Graham C; Cuschieri K
J Clin Pathol; 2015 Jul; 68(7):567-70. PubMed ID: 25878328
[TBL] [Abstract][Full Text] [Related]
17. Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL.
Lyons YA; Kamat AA; Zhou H; Mody DR; Schwartz MR; Hobday C; Ge Y
Cancer Cytopathol; 2015 Jul; 123(7):435-42. PubMed ID: 25903015
[TBL] [Abstract][Full Text] [Related]
18. The human papillomavirus Test of Cure: A lesson on compliance with the NHMRC guidelines on screening to prevent cervical cancer.
Munro A; Spilsbury K; Leung Y; O'Leary P; Williams V; Codde J; Steel N; Cohen P; Semmens J
Aust N Z J Obstet Gynaecol; 2015 Apr; 55(2):185-90. PubMed ID: 25871948
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening by human papillomavirus testing followed by cytology triage.
Giorgi-Rossi P; Arbyn M; Meijer CJ
JAMA Intern Med; 2015 Jun; 175(6):1068. PubMed ID: 26030858
[No Abstract] [Full Text] [Related]
20. Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007.
Weinmann S; Williams AE; Kamineni A; Buist DS; Masterson EE; Stout NK; Stark A; Ross TR; Owens CL; Field TS; Doubeni CA
Cancer; 2015 Sep; 121(17):2976-83. PubMed ID: 25989253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
